期刊文献+

帕金森病中K_(ATP)通道的研究进展 被引量:1

下载PDF
导出
摘要 近年来,发现离子通道异常参与帕金森病(PD)的发病,故帕金森病在某种意义上是一种'离子通道病'。KATP通道作为一种新型离子通道,得到广泛关注。随着中枢神经系统KATP通道研究的不断深入,其在帕金森病发病机制及治疗中的研究也取得了初步进展,本文就此作一综述。
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2012年第2期188-189,共2页 Journal of Apoplexy and Nervous Diseases
  • 相关文献

二级参考文献10

  • 1王刚,祝延,孔德虎,陈生弟.离子通道病研究的现状和展望[J].生理科学进展,2004,35(3):251-254. 被引量:12
  • 2王刚,陈生弟,杜芸兰,范国华,陆国强.成年大鼠脑内ATP敏感性钾通道亚型mRNA表达的研究[J].神经解剖学杂志,2005,21(1):29-33. 被引量:2
  • 3Thomzig A, Pruss H, Veh RW. The Kit6. 1-protein, a pore-forming subunit of ATP-sensitive potassium channels, is prominently expressed by giant cholinergic intemeurons in the striatum of the rat brain. Brain Res, 2003;986:132 - 138
  • 4Thomzig A, Laube G, Pruss H et al. Pore-forming subunits of KATP channels, Kit6.1 and Kit6.2, display prominent differences in regional and cellular distribution in the rat brain. J Comp Neurol, 2005 ;484:313 - 330
  • 5Rodrigo GC, Standen NB. ATP-sensitive potassium channels. Curr Pharm Des, 2005;11:1915 - 1940
  • 6Liss B, Haeckel O, Wildmann J et al. K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat Neurosci, 2005 ; 8 : 1742 - 1751
  • 7Stephenson D, Ramirez A, Long J et al. Quantification of MPTP- induced dopaminergic neurodegeneration in the mouse substantia nigra by laser capture microdissection. J Neurosci Methods, 2007 ; 159:291 -299
  • 8Himeda T, Watanabe Y, Tounai H et al. Time dependent alterations of co-localization of S100beta and GFAP in the MPTP-treated mice. J Neural Transm,2006; 113 : 1887 - 1894
  • 9Chert LW, Yung KL, Chan YS. Reactive astrocytes as potential manipulation targets in novel cell replacement therapy of Parkinson's disease. Curr Drug Targets, 2005 ;6:821 - 833
  • 10Jakowec MW, Nixon K, Hogg E et al. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1, 2, 3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway. J Neurosci Res, 2004;76:539 -550

共引文献12

同被引文献26

  • 1Fabio B. Neural and Immune Mechanisms in the Pathogenesis of Parkinson' s Disease[J].Neuroimmune Pharmacol,2013,(1):189-201.
  • 2Etienne C,Peter J,FRPharm S. Pathogenesis of Parkinson's Disease[J].{H}Movement Disorders,2013,(1):24-30.
  • 3Roux P P,Blenis J. ERK and p38 MAPK-activated protein kinases:a family of protein kinases with diverse biological functions[J].{H}Microbiology and Molecular Biology Reviews,2004,(68):320-344.
  • 4Wapen S,Kooncumchoo P,Shavali S. Salsolinol,an endogenous neurotoxin,activates JNK and NF-κB signaling pathways in human neuroblastoma cells[J].{H}Neurochemical Research,2007,(6):443-450.
  • 5Lee K W,Junn E,Mouradian M M. DJ-l protects against oxidative damage by regulating he hioredoxin/ASK1 complex[J].{H}Neuroscience Research,2010,(3):203-208.
  • 6Rita P,Teresa C O,Ana C R. Peprint of:Revisiting oxidative stress and mitochondrial dysfuction in the pathogenesis of Parkinson diseaseresemblance to the effect of amphetamine drugs of abuse[J].{H}Free Radical Biology and Medicine,2013,(1):186-201.
  • 7Li X,Du Y,Fan X. c-jun Kinase mediates lacacystin-induced dopamine neuron degeneration[J].Neuropathol Exp Neurol,2008,(10):933-944.
  • 8Awasthi Y C,Sharma R,Cheng J Z. Role of 4-hydroxynonenal in stress-mediated apnptosis signaling[J].{H}Molecular Aspects of Medicine,2003,(45):29-230.
  • 9Craig R,Larkin A,Mingo A M. p38 MAPK and NF-kappa B collaborate to induce interleukin-6gene expression and release.Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system[J].{H}Journal of Biological Chemistry,2000,(31):23814-23824.
  • 10Long-Smith C M,Sullivon A M,Nolan Y M. The influence of mictoglia on the pathogenesis of Parkinson' s Disease[J].{H}Progress in Neurobiology,2009,(3):277-287.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部